Notice of Intent To Grant a Partially Exclusive Patent License; RMZ Biotech, Inc.

Özet

The Department of the Navy hereby gives notice of its intent to grant to RMZ Biotech, Inc., a revocable, nonassignable, partially exclusive, license to practice worldwide the Government-Owned invention described in U.S. Patent Number 5,895,651 entitled "Recombinant Dengue Virus Envelop Protein/Maltose-Binding Protein Antigens and Subunit Vaccine Compositions Containing Said Antigens," issued 20 April 1999, in the field of rapid diagnostic test kits for Dengue Virus infection.